ProQR Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	106.88	149.41	118.93	94.78	187.52	75.84
Cash & Short-Term Investments	106.88	149.41	118.93	94.78	187.52	75.84
Cash Growth	19.55%	25.63%	25.48%	-49.46%	147.27%	-32.26%
Accounts Receivable	-	-	-	56.25	-	-
Other Receivables	2.55	2.03	1.27	0.98	0.82	0.8
Receivables	2.55	2.03	1.27	57.24	0.82	0.8
Prepaid Expenses	1.9	2.41	0.79	2.45	3.14	3.38
Total Current Assets	111.33	153.85	120.99	154.46	191.48	80.02
Property, Plant & Equipment	13.02	14.11	16.9	16.24	17.47	18.6
Long-Term Investments	-	-	-	0.62	0.63	0.11
Total Assets	124.35	167.96	137.88	171.32	209.58	98.73
Accounts Payable	0.31	0.02	1.54	0.39	0.19	0.22
Accrued Expenses	0.12	1.48	1.66	1.12	1.23	6.15
Current Portion of Long-Term Debt	4.8	4.58	-	2.5	4.77	1.14
Current Portion of Leases	1.67	1.57	1.61	1.39	1.53	1.26
Current Unearned Revenue	17.39	21.94	20.57	5.64	5.12	0.7
Other Current Liabilities	8.84	9.32	8.82	9.95	14.76	0.84
Total Current Liabilities	33.14	38.9	34.2	20.99	27.6	10.3
Long-Term Debt	-	-	4.29	4.27	39.32	16.19
Long-Term Leases	10.02	11.07	13.83	13.81	14.75	15.69
Long-Term Unearned Revenue	24.13	29.43	44.17	65.57	14.69	-
Total Liabilities	67.28	79.4	96.49	104.64	96.35	42.18
Common Stock	4.31	4.31	3.37	3.37	3	2.17
Additional Paid-In Capital	483.88	483.81	412.89	412.54	398.31	288.76
Retained Earnings	-458.71	-427.16	-400.85	-379.11	-317.77	-257.75
Comprehensive Income & Other	27.59	27.6	25.98	30.26	30.3	23.92
Total Common Equity	57.07	88.56	41.39	67.07	113.83	57.09
Minority Interest	-	-	-	-0.38	-0.6	-0.55
Shareholders' Equity	57.07	88.56	41.39	66.68	113.23	56.55
Total Liabilities & Equity	124.35	167.96	137.88	171.32	209.58	98.73
Total Debt	16.49	17.22	19.73	21.97	60.37	34.28
Net Cash (Debt)	90.39	132.19	99.19	72.8	127.15	41.56
Net Cash Growth	25.54%	33.27%	36.24%	-42.74%	205.94%	-57.76%
Net Cash Per Share	0.87	1.54	1.22	1.02	1.98	0.83
Filing Date Shares Outstanding	105.35	105.21	81.35	80.82	71.29	50.2
Total Common Shares Outstanding	105.35	105.21	81.35	80.82	71.29	50.2
Working Capital	78.2	114.94	86.78	133.47	163.89	69.72
Book Value Per Share	0.54	0.84	0.51	0.83	1.60	1.14
Tangible Book Value	57.07	88.56	41.39	67.07	113.83	57.09
Tangible Book Value Per Share	0.54	0.84	0.51	0.83	1.60	1.14
Buildings	-	23.79	24.78	22.86	22.23	21.64
Machinery	-	6.82	5.91	4.91	4.25	3.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.